PLN phosphorylation signalling

1. Baltas, L.G. et al. 1997a. The endogenous cardiac sarcoplasmic reticulum Ca2+/calmodulin-dependent kinase is activated in response to β-adrenergic stimulation and becomes Ca2+-independent in intact beating hearts. FEBS Letters. 409(2), pp.131-136.
2. Baltas, L.G. et al. 1997b. Effects of zinc on phospholamban phosphorylation. Biochem Biophys Res Commun. 232(2), pp.394-7.
3. Baltas, L.G. et al. 1997c. Effects of zinc on phospholamban phosphorylation. Biochemical and Biophysical Research Communications. 232(2), pp.394-397.
4. Bartel, S. et al. 2003. New insights into beta(2)-adrenoceptor signaling in the adult rat heart. Cardiovascular Research. 57(3), pp.694-703.
5. Bartel, S. et al. 2000. Phosphorylation of phospholamban at threonine-17 in the absence and presence of beta-adrenergic stimulation in neonatal rat cardiomyocytes. Journal of Molecular and Cellular Cardiology. 32(12), pp.2173-2185.
6. Bhupathy, P. et al. 2009. Threonine-5 at the N-terminus can modulate sarcolipin function in cardiac myocytes. Journal of Molecular and Cellular Cardiology. 47(5), pp.723-729.
7. Boknik, P. et al. 2000a. Protein phosphatase activity is increased in a rat model of long-term beta-adrenergic stimulation. Naunyn-Schmiedebergs Archives of Pharmacology. 362(3), pp.222-231.
8. Boknik, P. et al. 2000b. Protein phosphatase activity is increased in a rat model of long-term beta-adrenergic stimulation. Naunyn Schmiedebergs Arch Pharmacol. 362(3), pp.222-31.
9. Boknik, P. et al. 2001a. Enhanced protein phosphorylation in hypertensive hypertrophy. Cardiovascular Research. 51(4), pp.717-728.
10. Boknik, P. et al. 2001b. Role of protein phosphatases in regulation of cardiac inotropy and relaxation. American Journal of Physiology-Heart and Circulatory Physiology. 280(2), pp.H786-H794.
11. Boknik, P. et al. 2001c. Role of protein phosphatases in regulation of cardiac inotropy and relaxation. Am J Physiol Heart Circ Physiol. 280(2), pp.H786-94.
12. Boknik, P. et al. 1999. Regional expression of phospholamban in the human heart. Cardiovascular Research. 43(1), pp.67-76.
13. Brixius, K. et al. 2003. Ser16-, but not Thr17-phosohorylation of phospholamban influences frequency-dependent force generation in human myocardium. European Heart Journal. 24, pp.16-16.
14. Calaghan, S. et al. 1998a. Preservation of the in vivo phosphorylation status of phospholamban in the heart: Evidence for a site-specific difference in the dephosphorylation of phospholamban. Biochemical and Biophysical Research Communications. 248(3), pp.701-705.
15. Calaghan, S.C. et al. 1998b. Co-ordinated changes in cAMP, phosphorylated phospholamban, Ca2+ and contraction following beta-adrenergic stimulation of rat heart. Pflugers Archiv-European Journal of Physiology. 436(6), pp.948-956.
16. Catalucci, D. et al. 2009. At Increases Sarcoplasmic Reticulum Ca2+ Cycling by Direct Phosphorylation of Phospholamban at Thr(17). Journal of Biological Chemistry. 284(41), pp.28180-28187.
17. Cerra, M.C. and Imbrogno, S. 2012. Phospholamban and cardiac function: a comparative perspective in vertebrates. Acta Physiologica. 205(1), pp.9-25.
18. Cha, H. et al. 2008. PICOT is a critical regulator of cardiac hypertrophy and cardiomyocyte contractility. Journal of Molecular and Cellular Cardiology. 45(6), pp.796-803.
19. Colyer, J. 1998. Phosphorylation states of phospholamban. Cardiac Sarcoplasmic Reticulum Function and Regulation of Contractility. 853, pp.79-91.
20. Colyer, J. 2009. Analyzing Protein Phosphorylation. Protein Protocols Handbook, Third Edition. pp.1547-1553.
21. Colyer, J. 2014. Agents for and method of quantifying binding. Google Patents. Available from: http://www.google.com/patents/CA2552548C?cl=en10
22. Currie, S. and Smith, G.L. 1999. Enhanced phosphorylation of phospholamban and downregulation of sarco/endoplasmic reticulum Ca2+ ATPase type 2 (SERCA 2) in cardiac sarcoplasmic reticulum from rabbits with heart failure. Cardiovascular Research. 41(1), pp.135-146.
23. Czernik, A. et al. 1997. Phosphorylation State-Specific Antibodies. In: Hemmings, H., Jr. ed. Regulatory Protein Modification.   Humana Press, pp.219-250.
24. El-Armouche, A. et al. 2006. Role of calcineurin and protein phosphatase-2A in the regulation of phosphatase inhibitor-1 in cardiac myocytes. Biochemical and Biophysical Research Communications. 346(3), pp.700-706.
25. Freire, P.P. et al. 2014. Obesity does not lead to imbalance between myocardial phospholamban phosphorylation and dephosphorylation. Arq Bras Cardiol. 103(1), pp.41-50.
26. Gao, M.H. et al. 2008. Adenylyl Cyclase Type VI Increases Akt Activity and Phospholamban Phosphorylation in Cardiac Myocytes. Journal of Biological Chemistry. 283(48), pp.33527-33535.
27. Gergs, U. et al. 2009. Phosphorylation of phospholamban and troponin I through 5-HT4 receptors in the isolated human atrium. Naunyn-Schmiedebergs Archives of Pharmacology. 379(4), pp.349-359.
28. Gombosova, I. et al. 1998. Postnatal changes in contractile time parameters, calcium regulatory proteins, and phosphatases. American Journal of Physiology-Heart and Circulatory Physiology. 274(6), pp.H2123-H2132.
29. Hagemann, D. et al. 2000a. Frequency-encoding Thr17 phospholamban phosphorylation is independent of Ser16 phosphorylation in cardiac myocytes. J Biol Chem. 275(29), pp.22532-6.
30. Hagemann, D. et al. 2000b. Frequency-encoding Thr(17) phospholamban phosphorylation is independent of Ser(16) phosphorylation in cardiac myocytes. Journal of Biological Chemistry. 275(29), pp.22532-22536.
31. Hagemann, D. and Xiao, R.P. 2002. Dual site phospholamban phosphorylation and its physiological relevance in the heart. Trends Cardiovasc Med. 12(2), pp.51-6.
32. Haworth, R.S. et al. 2011. Regulation by phosphodiesterase isoforms of protein kinase A-mediated attenuation of myocardial protein kinase D activation. Basic Research in Cardiology. 106(1), pp.51-63.
33. Huke, S. and Bers, D.M. 2007. Temporal dissociation of frequency-dependent acceleration of relaxation and protein phosphorylation by CaMKII. J Mol Cell Cardiol. 42(3), pp.590-9.
34. Huke, S. and Bers, D.M. 2008. Ryanodine receptor phosphorylation at Serine 2030, 2808 and 2814 in rat cardiomyocytes. Biochemical and Biophysical Research Communications. 376(1), pp.80-85.
35. Inagaki, M. et al. 1997. Phosphorylation-dependent control of structures of intermediate filaments: a novel approach using site- and phosphorylation state-specific antibodies. J Biochem. 121(3), pp.407-14.
36. Jiang, M. et al. 2004. Coordinate downregulation of CaM kinase II and phospholamban accompanies contractile phenotype transition in the hyperthyroid rabbit soleus. American Journal of Physiology-Cell Physiology. 287(3), pp.C622-C632.
37. Kaasik, A. et al. 2001. Decreased expression of phospholamban is not associated with lower beta-adrenergic activation in rat atria. Mol Cell Biochem. 223(1-2), pp.109-15.
38. Kaumann, A.J. et al. 1996. Beta 2-adrenoceptor activation by zinterol causes protein phosphorylation, contractile effects and relaxant effects through a cAMP pathway in human atrium. Mol Cell Biochem. 163-164, pp.113-23.
39. Kirchhefer, U. et al. 2005. Enhanced cardiac function in mice overexpressing protein phosphatase inhibitor-2. Cardiovascular Research. 68(1), pp.98-108.
40. Kuschel, M. et al. 1999a. Ser(16) prevails over Thr(17) phospholamban phosphorylation in the beta-adrenergic regulation of cardiac relaxation. American Journal of Physiology-Heart and Circulatory Physiology. 276(5), pp.H1625-H1633.
41. Kuschel, M. et al. 1999b. Gi Protein-mediated Functional Compartmentalization of Cardiac β2-Adrenergic Signaling. Journal of Biological Chemistry. 274(31), pp.22048-22052.
42. Kuschel, M. et al. 1999c. beta(2)-adrenergic cAMP signaling is uncoupled from phosphorylation of cytoplasmic proteins in canine heart. Circulation. 99(18), pp.2458-2465.
43. Larsen, K.O. et al. 2008. Diastolic dysfunction in alveolar hypoxia: a role for interleukin-18-mediated increase in protein phosphatase 2A. Cardiovascular Research. 80(1), pp.47-54.
44. Larsen, K.O. et al. 2006. Alveolar hypoxia induces left ventricular diastolic dysfunction and reduces phosphorylation of phospholamban in mice. American Journal of Physiology-Heart and Circulatory Physiology. 291(2), pp.H507-H516.
45. Li, B.L. et al. 2006. Signaling pathways regulating murine cardiac CREB phosphorylation. Biochemical and Biophysical Research Communications. 350(1), pp.179-184.
46. Liu, S. et al. 2012. Phosphodiesterases coordinate cAMP propagation induced by two stimulatory G protein-coupled receptors in hearts. Proc Natl Acad Sci U S A. 109(17), pp.6578-83.
47. Mattiazzi, A. et al. 2005. Role of phospholamban phosphorylation on Thr(17) in cardiac physiological and pathological conditions. Cardiovascular Research. 68(3), pp.366-375.
48. Mayer, E.J. et al. 2000. Characterization and quantitation of phospholamban and its phosphorylation state using antibodies. Biochemical and Biophysical Research Communications. 267(1), pp.40-48.
49. Medeiros, A. et al. 2008. Exercise training delays cardiac dysfunction and prevents calcium handling abnormalities in sympathetic hyperactivity-induced heart failure mice. Journal of Applied Physiology. 104(1), pp.103-109.
50. Munch, G. et al. 2000. SERCA2a activity correlates with the force-frequency relationship in human myocardium. American Journal of Physiology-Heart and Circulatory Physiology. 278(6), pp.H1924-H1932.
51. Mundina-Weilenmann, C. et al. 1996. Immunodetection of phosphorylation sites gives new insights into the mechanisms underlying phospholamban phosphorylation in the intact heart. J Biol Chem. 271(52), pp.33561-7.
52. Mundina-Weilenmann, C. et al. 2000. Endoplasmic reticulum contribution to the relaxant effect of cGMP- and cAMP-elevating agents in feline aorta. American Journal of Physiology-Heart and Circulatory Physiology. 278(6), pp.H1856-H1865.
53. Ng, J. and Cantrell, D. 1997. STAT3 is a serine kinase target in T lymphocytes. Interleukin 2 and T cell antigen receptor signals converge upon serine 727. J Biol Chem. 272(39), pp.24542-9.
54. Prasad, V. et al. 2008. Impaired Cardiac Contractility in Mice Lacking Both the AE3 Cl-/HCO3- Exchanger and the NKCC1 Na+-K+-2Cl(-) Cotransporter EFFECTS ON Ca2+ HANDLING AND PROTEIN PHOSPHATASES. Journal of Biological Chemistry. 283(46), pp.31303-31314.
55. Rodriguez, P. et al. 2007. Phosphorylation of human inhibitor-1 at Ser67 and/or Thr75 attenuates stimulatory effects of protein kinase A signaling in cardiac myocytes. Am J Physiol Heart Circ Physiol. 293(1), pp.H762-9.
56. Rolim, N.P.L. et al. 2007. Exercise training improves the net balance of cardiac Ca2+ handling protein expression in heart failure. Physiological Genomics. 29(3), pp.246-252.
57. Roof, S.R. et al. 2011. Effects of increased systolic Ca(2)(+) and phospholamban phosphorylation during beta-adrenergic stimulation on Ca(2)(+) transient kinetics in cardiac myocytes. Am J Physiol Heart Circ Physiol. 301(4), pp.H1570-8.
58. Simmerman, H.K.B. and Jones, L.R. 1998. Phospholamban: Protein structure, mechanism of action, and role in cardiac function. Physiological Reviews. 78(4), pp.921-947.
59. Singh, P. et al. 2009. Alpha-kinase anchoring protein alphaKAP interacts with SERCA2A to spatially position Ca2+/calmodulin-dependent protein kinase II and modulate phospholamban phosphorylation. J Biol Chem. 284(41), pp.28212-21.
60. Snabaitis, A.K. et al. 2006. A novel role for protein phosphatase 2A in receptor-mediated regulation of the cardiac sarcolemmal Na+/H+ exchanger NHE1. Journal of Biological Chemistry. 281(29), pp.20252-20262.
61. Sulakhe, P.V. and Vo, X.T. 1995. Regulation of phospholamban and troponin-I phosphorylation in the intact rat cardiomyocytes by adrenergic and cholinergic stimuli: roles of cyclic nucleotides, calcium, protein kinases and phosphatases and depolarization. Mol Cell Biochem. 149-150, pp.103-26.
62. Sulakhe, P.V. et al. 1997. Protein phosphorylation in rat cardiac microsomes: effects of inhibitors of protein kinase A and of phosphatases. Mol Cell Biochem. 175(1-2), pp.109-15.
63. Tschope, C. et al. 2004. Improvement of defective sarcoplasmic reticulum Ca2+ transport in diabetic heart of transgenic rats expressing the human kallikrein-1 gene. Faseb j. 18(15), pp.1967-9.
64. Valverde, C.A. et al. 2005. Frequency-dependent acceleration of relaxation in mammalian heart: a property not relying on phospholamban and SERCA2a phosphorylation. J Physiol. 562(Pt 3), pp.801-13.
65. Valverde, C.A. et al. 2006. Phospholamban phosphorylation sites enhance the recovery of intracellular Ca2+ after perfusion arrest in isolated, perfused mouse heart. Cardiovascular Research. 70(2), pp.335-345.
66. Vasanji, Z. et al. 2006. Alterations in cardiac contractile performance and sarcoplasmic reticulum function in sucrose-fed rats is associated with insulin resistance. American Journal of Physiology-Cell Physiology. 291(4), pp.C772-C780.
67. Wanichawan, P. et al. 2011. Full-length cardiac Na+/Ca2+ exchanger 1 protein is not phosphorylated by protein kinase A. Am J Physiol Cell Physiol. 300(5), pp.C989-97.
68. Xu, X.D. et al. 2005. ASF/SF2-Regulated CaMKII delta alternative splicing temporally reprograms excitation-contraction coupling in cardiac muscle. Cell. 120(1), pp.59-72.
69. Yamada, M. et al. 2006. Inhibition of protein phosphatase 1 by inhibitor-2 gene delivery ameliorates heart failure progression in genetic cardiomyopathy. Faseb Journal. 20(8), pp.1197-+.
70. Zhang, R. et al. 2005. Calmodulin kinase II inhibition protects against structural heart disease. Nature Medicine. 11(4), pp.409-417.
71. Zhao, W. et al. 2004. Threonine-17 phosphorylation of phospholamban: a key determinant of frequency-dependent increase of cardiac contractility. Journal of Molecular and Cellular Cardiology. 37(2), pp.607-612.
72. Zhao, X.Y. et al. 2008. rAAV-asPLB transfer attenuates abnormal sarcoplasmic reticulum Ca2+-ATPase activity and cardiac dysfunction in rats with myocardial infarction. European Journal of Heart Failure. 10(1), pp.47-54.
73. Zhou, X.W. et al. 2007. Proteomic. studies of PP2A-B56 gamma 1 phosphatase complexes reveal phosphorylation-regulated partners in cardiac local signaling. Journal of Proteome Research. 6(9), pp.3433-3442.

Back to main infographic.